Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA).

Autor:	Holm M; International Vaccine Institute, Seoul, Republic of Korea., MacWright WR; Public Health Surveillance Group LLC, Princeton, New Jersey, USA., Poudyal N; International Vaccine Institute, Seoul, Republic of Korea., Shaw AG; Public Health Surveillance Group LLC, Princeton, New Jersey, USA., Joh HS; International Vaccine Institute, Seoul, Republic of Korea., Gallagher PF; Public Health Surveillance Group LLC, Princeton, New Jersey, USA., Kim JH; International Vaccine Institute, Seoul, Republic of Korea., Shaikh AT; Public Health Surveillance Group LLC, Princeton, New Jersey, USA., Seo HJ; International Vaccine Institute, Seoul, Republic of Korea., Kwon SY; International Vaccine Institute, Seoul, Republic of Korea., Prifti K; International Vaccine Institute, Seoul, Republic of Korea., Dolabella B; Public Health Surveillance Group LLC, Princeton, New Jersey, USA., Taylor BEW; Centre for Genomic Pathogen Surveillance, Big Data Institute, Oxford University, Oxford, United Kingdom., Yeats C; Centre for Genomic Pathogen Surveillance, Big Data Institute, Oxford University, Oxford, United Kingdom., Aanensen DM; Centre for Genomic Pathogen Surveillance, Big Data Institute, Oxford University, Oxford, United Kingdom., Stelling J; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Marks F; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Dec 20; Vol. 77 (Suppl 7), pp. S500-S506.
DOI:	10.1093/cid/ciad567
Abstrakt:	Background: In 2015, the UK government established the Fleming Fund with the aim to address critical gaps in surveillance of antimicrobial resistance (AMR) in low- and middle-income countries in Asia and Africa. Among a large portfolio of grants, the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project was awarded with the specific objective of expanding the volume of historical data on AMR, consumption (AMC), and use (AMU) in the human healthcare sector across 12 countries in South and Southeast Asia. Methods: Starting in early 2019, the CAPTURA consortium began working with local governments and >100 relevant data-holding facilities across the region to identify, assess for quality, prioritize, and subsequently retrieve data on AMR, AMC, and AMU. Relevant and shared data were collated and analyzed to provide local overviews for national stakeholders as well as regional context, wherever possible. Results: From the vast information resource generated on current surveillance capacity and data availability, the project has highlighted gaps and areas for quality improvement and supported comprehensive capacity-building activities to optimize local data-collection and -management practices. Conclusions: The project has paved the way for expansion of surveillance networks to include both the academic and private sector in several countries and has actively engaged in discussions to promote data sharing at the local, national, and regional levels. This paper describes the overarching approach to, and emerging lessons from, the CAPTURA project, and how it contributes to other ongoing efforts to strengthen national AMR surveillance in the region and globally. Competing Interests: Potential conflicts of interest. A. G. S., P. F. G., A. T. S., and D. B. report grant funding from the Public Health Surveillance Group. H. S. J. reports being an employee with the International Vaccine Institute since 2021; they also received consultancy fees from the CAPTURA project between 2019 and 2021. J. S. reports salary support through a subcontract from the International Vaccine Institute. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu